anti-Class II Transactivator (CIITA) Antikörper

Essential for transcriptional activity of the HLA class II promoter\; activation is via the proximal promoter.

Alle Antikörper anzeigen Gen GeneID UniProt
CIITA 12265 P79621
CIITA    
CIITA    
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top anti-Class II Transactivator Antikörper auf antikoerper-online.de

Showing 3 out of 3 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Anbieter Lieferzeit Preis Details
Hund Kaninchen Unkonjugiert WB <b>WB Suggested Anti-C2TA Antibody Titration: </b>0.125ug/ml<br><b>ELISA Titer: </b>1:62500<br><b>Positive Control: </b>NIH/3T3 cell lysate 100 μL Anmelden zum Anzeigen 2 bis 3 Tage
$289.00
Details
Maus Kaninchen Unkonjugiert ELISA, WB 50 μg Anmelden zum Anzeigen 2 bis 3 Tage
$433.13
Details
Maus Kaninchen Unkonjugiert WB C2TA antibody used at 0.2-1 ug/ml to detect target protein. 50 μg Anmelden zum Anzeigen 6 bis 8 Tage
$473.93
Details

CIITA Antikörper nach Reaktivität, Anwendung, Klonalität and Konjugat

Attribute Applikationen Wirt Klonalität
Mouse (Murine)


Dog (Canine)


Rat (Rattus)


Weitere Antikörper gegen Class II Transactivator Interaktionspartner

Mouse (Murine) Class II Transactivator (CIITA) Interaktionspartner

  1. study found that CIITA exerts a highly restricted control over only the MHCII, H2-DO and H2-DM genes, in DC1 and DC2 cDC (zeige CDK1 Antikörper) subsets, but not over other proposed targets

  2. Decreasing CIITA expression in allogeneic MSCs abolished MHC II induction during myogenic differentiation and prevented immunorejection of these cells from the infarcted myocardium, which enhanced beneficial functional effects of MSC (zeige MSC Antikörper) implantation on myocardial repair.

  3. M. tuberculosis EsxL inhibits antigen presentation by enhancing H3K9me2/3 at the CIITA promoter, thereby repressing its expression through NO and p38 MAPK (zeige MAPK14 Antikörper) activation

  4. this study shows that genetic polymorphisms in the type I promoter of C2ta regulate MHC-II expression and T-cell responses but do not necessarily have a strong impact on autoimmune diseases

  5. CIITA interacted with and recruited PRMT5 to the MHC II promoter and mediated the synergy between PRMT5 and ASH2/WDR5 to activate MHC II transcription

  6. NLRC5 (zeige NLRC5 Antikörper) and CIITA thus emerge as paradigms for a novel class of transcriptional regulators dedicated for transactivating extremely few, phylogenetically related genes.

  7. Data suggest that class II transactivator CIITA expression is likely mediated in hematopoietic cells by common elements with promoter accessibility having a part in promoter choice.

  8. Transfection of CIITA in poorly immunogenic PDA cells resulted in increased expression levels of the MHC class II molecule. CIITA-tumor cells were rejected in 80% to 100% of injected mice.

  9. IFN-gamma exerts a critical anti-inflammatory function in the intestine which protects against colitis by inducing MHCII expression on intestinal epithelial cells.

  10. tumor cell lines with a defective expression of CIITA transcripts lack MHC class II expression

Class II Transactivator (CIITA) Antigen-Profil

Protein Überblick

Essential for transcriptional activity of the HLA class II promoter\; activation is via the proximal promoter. No DNA binding of in vitro translated CIITA was detected. May act in a coactivator-like fashion through protein-protein interactions by contacting factors binding to the proximal MHC class II promoter, to elements of the transcription machinery, or both. Alternatively it may activate HLA class II transcription by modifying proteins that bind to the MHC class II promoter (By similarity).

Genbezeichner und Symbole assoziert mit CIITA

  • class II transactivator (Ciita) Antikörper
  • C2ta Antikörper
  • EG669998 Antikörper
  • Gm9475 Antikörper

Bezeichner auf Proteinebene für CIITA

MHC class II transactivator

GENE ID SPEZIES
12265 Mus musculus
Ausgewählte Anbieter für anti-Class II Transactivator (CIITA) Antikörper
Haben Sie etwas anderes gesucht?